China Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery

  • 78 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
78
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
1
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. China Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin DeliveryReport Details:Published:September 2012No. of Pages: 91Price: Single User License – US$2500China Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin DeliverySummaryGlobalData’s new report, “China Diabetes Care Devices Market Outlook to 2018- GlucoseMonitoring and Insulin Delivery” provides key market data on the China Diabetes Care Devicesmarket. The report provides value (USD million), volume (units) and average price (USD) data foreach segment and sub-segment within two market categories – Glucose Monitoring and InsulinDelivery. The report also provides company shares and distribution shares data for each of theaforementioned market categories. The report is supplemented with global corporate-level profilesof the key market participants with information on company financials and pipeline products,wherever available.This report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GlobalData’s team of industry experts.Scope- Market size and company share data for Diabetes Care Devices market categories – GlucoseMonitoring and Insulin Delivery.- Annualized market revenues (USD million), volume (units) and average price (USD) data foreach of the segments and sub-segments within two market categories. Data from 2004 to 2011,forecast forward for 7 years to 2018.- 2011 company shares and distribution shares data for each of the two market categories.- Global corporate-level profiles of key companies operating within the China Diabetes CareDevicesmarket.- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Inc., NovoNordisk A/S, Abbott Laboratories, Becton, Dickinson and Company and others.
  • 2. Reasons to buy- Develop business strategies by identifying the key market categories and segments poised forstrong growth.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the China Diabetes CareDevices competitive landscape.- Develop capital investment strategies by identifying the key market segments expected toregister strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of productdistribution – Identify, understand and capitalize.Get your copy of this report @http://www.reportsnreports.com/reports/197485-china-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 21.1 List of Tables 61.2 List of Figures 72 Introduction 92.1 What is This Report About? 93 Diabetes Care Devices In China 103.1 Diabetes Care Devices, Market Segmentation 103.2 Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 113.3 Diabetes Care Devices Market, China, Revenue Mix ($m), 2011 123.4 Diabetes Care Devices Market, China, Category Contribution (%), 2011 133.5 Diabetes Care Devices, China, Company Share (2010-2011) 184 Glucose Monitoring In China 204.1 Glucose Monitoring, Market Segmentation 204.2 Glucose Monitoring Market, China, Revenue Mix ($m), 2011 214.3 Glucose Monitoring Market, China, Segment Contribution (%), 2011 224.4 Glucose Monitoring Overall Revenue, (2004-2018) 234.4.1 Blood Glucose Meters, Revenue (2004-2018) 274.5 Glucose Monitoring Overall Volume (2004-2018) 314.5.1 Blood Glucose Meters, Volume (2004-2018) 354.6 Glucose Monitoring Average Price (2004-2018) 384.7 Glucose Monitoring Distribution Share (2010-2011) 394.8 Glucose Monitoring, China, Company Share (2010-2011) 405 Insulin Delivery In China 425.1 Insulin Delivery, Market Segmentation 425.2 Insulin Delivery Market, China, Revenue Mix ($m), 2011 43
  • 3. 5.3 Insulin Delivery Market, China, Segment Contribution (%), 2011 445.4 Insulin Delivery Overall Revenue, (2004-2018) 455.4.1 Insulin Pens, Revenue (2004-2018) 495.4.2 Insulin Pumps, Revenue (2004-2018) 535.5 Insulin Delivery Overall Volume (2004-2018) 555.5.1 Insulin Pens, Volume (2004-2018) 595.5.2 Insulin Pumps, Volume (2004-2018) 635.6 Insulin Delivery Average Price (2004-2018) 655.7 Insulin Delivery Distribution Share (2010-2011) 665.8 Insulin Delivery, China, Company Share (2010-2011) 676 Overview of Key Companies in China Diabetes Care Devices Market 696.1 LifeScan, Inc. 696.1.1 Company Overview 696.1.2 Share in the China Diabetes Care Devices Market 696.2 F. Hoffmann-La Roche Ltd. 706.2.1 Company Overview 706.2.2 Share in the China Diabetes Care Devices Market 706.3 Medtronic, Inc. 716.3.1 Company Overview 716.3.2 Share in the China Diabetes Care Devices Market 716.4 Novo Nordisk A/S 726.4.1 Company Overview 726.4.2 Share in the China Diabetes Care Devices Market 726.5 Abbott Laboratories 736.5.1 Company Overview 736.5.2 Share in the China Diabetes Care Devices Market 736.6 Becton, Dickinson and Company 746.6.1 Company Overview 746.6.2 Share in the China Diabetes Care Devices Market 746.7 ARKRAY, Inc. 756.7.1 Company Overview 756.8 Bayer HealthCare AG 756.8.1 Company Overview 756.9 Eli Lilly and Company 756.9.1 Company Overview 756.10 Sanofi 766.10.1 Company Overview 766.11 Animas Corporation 766.11.1 Company Overview 766.12 Terumo Corporation 766.12.1 Company Overview 767 Diabetes Care Devices Market Pipeline Products 77
  • 4. 8 Financial Deals Landscape 808.1 Partnerships 808.1.1 Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 808.1.2 Insulet Expands Distribution Agreement With Ypsomed Holding 829 Recent Developments 839.1 Strategy And Business Planning 839.1.1 Aug 28, 2012: Medtronic Opens Shanghai Innovation Center 839.1.2 Aug 09, 2012: Takeda Establishes Development Center In China 839.2 Research And Development 849.2.1 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug DiscoveryPartnership 849.3 Legal and Regulatory 849.3.1 Apr 17, 2012: Sanmina-SCI Suzhou, China Facility Receives ISO 13485 Certification ForMedical Devices 8410 Appendix 8610.1 Definitions of Markets Covered in the Report 8710.1.1 Diabetes Care Devices 8710.2 Research Methodology 8910.3 Secondary Research 8910.4 Primary Research 9010.5 Models 9010.6 Forecasts 9010.7 Expert Panels 9110.8 GlobalData Consulting 9110.9 Currency Conversion 9110.10 Contact Us 9110.11 Disclaimer 911.1 List of TablesTable 1: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 11Table 2: Diabetes Care Devices Market, China, Category Contribution (%), 2011 13Table 3: Diabetes Care Devices, China, Cross-Segment Analysis, 2004-2018 15Table 4: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Table 5: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17Table 6: Diabetes Care Devices, China, Company Share by Revenue ($m), USD Constant, 2010-2011 19Table 7: Glucose Monitoring Market, China, Segment Contribution (%), 2011 22Table 8: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 24Table 9: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
  • 5. 2018 26Table 10: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 28Table 11: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 30Table 12: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2004-2011 32Table 13: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2011-2018 34Table 14: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 35Table 15: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 37Table 16: Glucose Monitoring, China, Average Price ($), Historic, 2004-2011 38Table 17: Glucose Monitoring, China, Average Price ($), Forecast, 2011-2018 38Table 18: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 39Table 19: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-2011 41Table 20: Insulin Delivery Market, China, Segment Contribution (%), 2011 44Table 21: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-201146Table 22: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 48Table 23: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 50Table 24: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 52Table 25: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,Historic, 2004-2011 53Table 26: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,Forecast, 2011-2018 54Table 27: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2004-2011 56Table 28: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2011-2018 58Table 29: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 60Table 30: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 62Table 31: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Historic, 2004-201163Table 32: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Forecast, 2011-201864Table 33: Insulin Delivery, China, Average Price ($), Historic, 2004-2011 65Table 34: Insulin Delivery, China, Average Price ($), Forecast, 2011-2018 65Table 35: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Constant, 2010-201166Table 36: Insulin Delivery, China, Company Share by Revenue ($m), USD Constant, 2010-201168
  • 6. Table 37: Diabetes Care Devices Market Pipeline Products 77Table 38: Bioton And SciGen Amend Distribution Agreement With Bayer HealthCare 80Table 39: Insulet Expands Distribution Agreement With Ypsomed Holding 821.2 List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10Figure 2: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 11Figure 3: Diabetes Care Devices Market, China, Revenue Mix ($m), 2011 12Figure 4: Diabetes Care Devices Market, China, Category Contribution (%), 2011 13Figure 5: Diabetes Care Devices, China, Cross-Segment Analysis, 2004-2018 14Figure 6: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16Figure 7: Diabetes Care Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 17Figure 8: Diabetes Care Devices, China, Company Share (%)-2011 18Figure 9: Glucose Monitoring, Market Segmentation 20Figure 10: Glucose Monitoring Market, China, Revenue Mix ($m), 2011 21Figure 11: Glucose Monitoring Market, China, Segment Contribution (%), 2011 22Figure 12: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 23Figure 13: Glucose Monitoring, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 25Figure 14: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment, Historic,2004-2011 27Figure 15: Blood Glucose Meters, China, Revenue ($m) USD Constant, by Sub-Segment,Forecast, 2011-2018 29Figure 16: Glucose Monitoring, China, Volume (Units) by Segment, Historic, 2004-2011 31Figure 17: Glucose Monitoring, China, Volume (Units) by Segment, Forecast, 2011-2018 33Figure 18: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 35Figure 19: Blood Glucose Meters, China, Volume (Units) by Sub-Segment, Forecast, 2011-201836Figure 20: Glucose Monitoring, China, Company Share (%), 2011 40Figure 21: Insulin Delivery, Market Segmentation 42Figure 22: Insulin Delivery Market, China, Revenue Mix ($m), 2011 43Figure 23: Insulin Delivery Market, China, Segment Contribution (%), 2011 44Figure 24: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Historic, 2004-201145Figure 25: Insulin Delivery, China, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 47Figure 26: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 49Figure 27: Insulin Pens, China, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-
  • 7. 2018 51Figure 28: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,Historic, 2004-2011 53Figure 29: Insulin Pumps (Traditional Insulin Pumps), China, Revenue ($m) USD Constant,Forecast, 2011-2018 54Figure 30: Insulin Delivery, China, Volume (Units) by Segment, Historic, 2004-2011 55Figure 31: Insulin Delivery, China, Volume (Units) by Segment, Forecast, 2011-2018 57Figure 32: Insulin Pens, China, Volume (Units) by Sub-Segment, Historic, 2004-2011 59Figure 33: Insulin Pens, China, Volume (Units) by Sub-Segment, Forecast, 2011-2018 61Figure 34: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Historic, 2004-201163Figure 35: Insulin Pumps (Traditional Insulin Pumps), China, Volume (Units), Forecast, 2011-201864Figure 36: Insulin Delivery, China, Company Share (%), 2011 67Figure 37: LifeScan, Inc., Company Share (%),China Diabetes Care Devices Market, 2011 69Figure 38: F. Hoffmann-La Roche Ltd., Company Share (%),China Diabetes Care Devices Market,2011 70Figure 39: Medtronic, Inc., Company Share (%),China Diabetes Care Devices Market, 2011 71Figure 40: Novo Nordisk A/S, Company Share (%),China Diabetes Care Devices Market, 2011 72Figure 41: Abbott Laboratories, Company Share (%),China Diabetes Care Devices Market, 201173Figure 42: Becton, Dickinson and Company, Company Share (%),China Diabetes Care DevicesMarket, 2011 74Contact: sales@reportsandreports.com for more information.